Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J9KC
|
|||
| Former ID |
DIB002060
|
|||
| Drug Name |
IGN-101
|
|||
| Synonyms |
Cancer vaccine, Igeneon; Anti-EpCam murine monoclonal antibody 17-A carcinoma vaccine; Aluminum-adsorbed murine monoclonal antibody 17-1A (edrecolomab) vaccine antigen (cancer), Igeneon
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Discontinued in Phase 2 | [1] | |
| Company |
Igeneon GmbH
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tumor-associated calcium signal transducer 1 (EPCAM) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013809) | |||
| REF 2 | Drug evaluation: IGN-101--an anti-EpCAM murine antibody vaccine for cancer. Curr Opin Mol Ther. 2006 Aug;8(4):358-65. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.